Literature DB >> 3957236

Ultrastructure of experimental cocaine hepatotoxicity.

M R Gottfried, M W Kloss, D Graham, E J Rauckman, G M Rosen.   

Abstract

Cocaine is a potent hepatotoxin in mice. It is converted in the liver by a minor oxidative pathway to the active metabolite, norcocaine nitroxide. Previous studies have shown evidence of a lipid peroxidative mechanism of toxicity, including increased conjugated diene absorption by hepatic microsomal lipids following a single 60 mg per kg i.p. dose of cocaine in DBA/2Ha mice. To explore this mechanism further, morphologic changes in the livers of DBA/2Ha mice were examined following the same dose of cocaine. The first ultrastructural change seen was dilatation of rough endoplasmic reticulum in centrilobular hepatocytes 1 hr following cocaine injection, coincident with the previously observed onset of increased conjugated diene absorption in microsomal lipids. During the previously observed period of peak conjugated diene absorption (2 to 4 hr), ultrastructural changes in centrilobular hepatocytes progressed. These included focal mitochondrial membrane disruption followed by more extensive mitochondrial swelling and disruption with increased swelling of rough endoplasmic reticulum. Changes in size, shape and concentration of histochemically labeled, morphometrically studied peroxisomes were also seen during this interval. Injury of centrilobular hepatocytes advanced to cell death in 6 to 8 hr. The time course and nature of these morphologic findings correlate with previously observed evidence of lipid peroxidation, supporting the hypothesis that this is the mechanism of cocaine hepatoxicity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3957236     DOI: 10.1002/hep.1840060224

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  6 in total

1.  Characterization of differential cocaine metabolism in mouse and rat through metabolomics-guided metabolite profiling.

Authors:  Dan Yao; Xiaolei Shi; Lei Wang; Blake A Gosnell; Chi Chen
Journal:  Drug Metab Dispos       Date:  2012-10-03       Impact factor: 3.922

2.  Lipidomic profiling reveals protective function of fatty acid oxidation in cocaine-induced hepatotoxicity.

Authors:  Xiaolei Shi; Dan Yao; Blake A Gosnell; Chi Chen
Journal:  J Lipid Res       Date:  2012-08-19       Impact factor: 5.922

Review 3.  Biomechanisms of cocaine-induced hepatocyte injury mediated by the formation of reactive metabolites.

Authors:  U A Boelsterli; C Göldlin
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

4.  Cocaine hepatotoxicity: a study on the pathogenesis of periportal necrosis.

Authors:  C J Powell; S J Charles; J Mullervy
Journal:  Int J Exp Pathol       Date:  1994-12       Impact factor: 1.925

Review 5.  The role of CYP enzymes in cocaine-induced liver damage.

Authors:  M Pasanen; P Pellinen; F Stenbäck; R O Juvonen; H Raunio; O Pelkonen
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

6.  Reversible Fulminant Hepatitis Secondary to Cocaine in the Setting of β-Blocker Use.

Authors:  Rohan Sharma; Nidhi Kapoor; Kaustubh Suresh Chaudhari; Robert Hal Scofield
Journal:  J Investig Med High Impact Case Rep       Date:  2020 Jan-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.